Abstract
Photodynamic therapy (PDT) is an emerging treatment modality for cancer as well as non-cancer diseases. PDT involves administration of a photosensitizer in targeted tissues and photogeneration of cytotoxic reactive oxygen species that destroys tumor cells. Much effort has been paid to disperse hydrophobic photosensitizers molecularly in water, since self-aggregation of photosensitizers significantly reduces singlet oxygen yield. The self-aggregation and the particle formation have, however, been revaluated and extended in terms of passive tumor cell targeting and ongoing nanotechnology. Upon systemic administration, nanoparticles are preferentially taken up by tumor tissues due to EPR effect (Enhanced Permeability and Retention Effect). To improve therapeutic efficacy and suppress side effects, a variety of approaches has been explored by using photosensitizer nanoparticles such as dendrimers, quantum dots, liposomes, polymer micelles, peptide-conjugates, and hydrogel nanoparticles. Control of the size, surface property, and amphiphilicity are key factors in optimizing the nano-PDT-agents. In this article, the author will review recent progress in this growing field, including our approaches, from the viewpoint of supramolecular chemistry and nanotechnology. Future subjects will also be discussed.
Keywords: Semiconductor quantum dots, MRI technique, dendrimer, liposomes, PLGA micelles
Current Bioactive Compounds
Title: Photosensitizer Nanoparticles for Photodynamic Therapy
Volume: 3 Issue: 4
Author(s): Toru Oba
Affiliation:
Keywords: Semiconductor quantum dots, MRI technique, dendrimer, liposomes, PLGA micelles
Abstract: Photodynamic therapy (PDT) is an emerging treatment modality for cancer as well as non-cancer diseases. PDT involves administration of a photosensitizer in targeted tissues and photogeneration of cytotoxic reactive oxygen species that destroys tumor cells. Much effort has been paid to disperse hydrophobic photosensitizers molecularly in water, since self-aggregation of photosensitizers significantly reduces singlet oxygen yield. The self-aggregation and the particle formation have, however, been revaluated and extended in terms of passive tumor cell targeting and ongoing nanotechnology. Upon systemic administration, nanoparticles are preferentially taken up by tumor tissues due to EPR effect (Enhanced Permeability and Retention Effect). To improve therapeutic efficacy and suppress side effects, a variety of approaches has been explored by using photosensitizer nanoparticles such as dendrimers, quantum dots, liposomes, polymer micelles, peptide-conjugates, and hydrogel nanoparticles. Control of the size, surface property, and amphiphilicity are key factors in optimizing the nano-PDT-agents. In this article, the author will review recent progress in this growing field, including our approaches, from the viewpoint of supramolecular chemistry and nanotechnology. Future subjects will also be discussed.
Export Options
About this article
Cite this article as:
Oba Toru, Photosensitizer Nanoparticles for Photodynamic Therapy, Current Bioactive Compounds 2007; 3 (4) . https://dx.doi.org/10.2174/157340707783220248
DOI https://dx.doi.org/10.2174/157340707783220248 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
CXCR4 and Glioblastoma
Anti-Cancer Agents in Medicinal Chemistry Targeting MDM2 and MDMX in Retinoblastoma
Current Cancer Drug Targets Current and Potential Anticancer Drugs Targeting Members of the UHRF1 Complex Including Epigenetic Modifiers
Recent Patents on Anti-Cancer Drug Discovery Ultrasound Therapeutics– A Review
Current Medical Imaging Protein Aggregation and Defective RNA Metabolism as Mechanisms for Motor Neuron Damage
CNS & Neurological Disorders - Drug Targets Butyrate and Colorectal Cancer: The Role of Butyrate Transport
Current Drug Metabolism Network Medicine and High Throughput Screening
Current Drug Discovery Technologies Signal Transduction Inhibitors in the Treatment of Breast Cancer
Current Medicinal Chemistry - Anti-Cancer Agents Genitourinary Tract Tumors in Children: An Update
Current Pediatric Reviews Synthetic Methods of Quinoline Derivatives as Potent Anticancer Agents
Mini-Reviews in Medicinal Chemistry Synthetic 2-Methoxyestradiol Derivatives: Structure-Activity Relationships
Current Medicinal Chemistry Proteasomes: A Complex Story
Current Protein & Peptide Science Patented Biomarkers for the Early Detection of Ovarian Cancer
Recent Patents on Biomarkers Peroxisome Proliferator Activated Receptor-Gamma Ligands as Potent Antineoplastic Agents
Current Medicinal Chemistry - Anti-Cancer Agents Mechanisms and Inhibitors of Apoptosis in Cardiovascular Diseases
Current Pharmaceutical Design Breaking the DNA Damage Response via Serine/Threonine Kinase Inhibitors to Improve Cancer Treatment
Current Medicinal Chemistry Small Molecule CDK Inhibitors for the Therapeutic Management of Cancer
Current Topics in Medicinal Chemistry Editorial (Personalized Medicine in the Age of Pharmacoproteomics: A Close up on India and Need for Social Science Engagement for Responsible Innovation in Post-Proteomic Biology)
Current Pharmacogenomics and Personalized Medicine Targeting the p53 Pathway of Apoptosis
Current Pharmaceutical Design Chlamydia-Secreted Proteins in Chlamydial Interactions with Host Cells
Current Chemical Biology